Multiplexing: Managing Risk with Proven, Single-Use Solutions

Multiplexing: Managing Risk with Proven, Single-Use SolutionsWhen pharmaceutical companies introduce a new drug to market, they invest enormous amounts of capital, and assume equally enormous amounts of risk. As it usually takes three-to-four years to prepare manufacturing capacity for the large scale production of a new product, the decision as to how much volume a company will need often must be made before Phase III trials are completed. At that point, it is difficult for developers to forecast demand. Therefore, deciding how much manufacturing capacity they will need is problematic, to say the least. Underestimating or overestimating demand can have a devastating impact on the bottom line.

Learn how you can manage the risk of introducing a new drug to market with proven, single-use solutions.

Author: Marc Goemans

Resource Library

Related Sites

Additional Resources